What is Ispecimen?
Founded to tackle the critical challenge of efficiently connecting life science researchers with the vast quantities of human biospecimens available in healthcare organizations, Ispecimen has developed the iSpecimen Marketplace®. This innovative platform is revolutionizing biospecimen procurement, thereby accelerating medical discovery. The company's approach streamlines the process, making it easier for researchers to access the materials they need for groundbreaking studies.
How much funding has Ispecimen raised?
Ispecimen has raised a total of $16.2M across 5 funding rounds:
Series A
$2M
Series B
$8.6M
Debt
$350K
Debt
$1M
Private Equity
$1.8M
Series A (2012): $2M with participation from MassChallenge
Series B (2014): $8.6M led by OneBlood
Debt (2020): $350K supported by PPP
Debt (2024): $1M, investors not publicly disclosed
Private Equity (2025): $1.8M, investors not publicly disclosed
Key Investors in Ispecimen
MassChallenge
MassChallenge is an organization dedicated to accelerating solutions in various sectors including Healthcare & Life Sciences, Security & Resiliency, Sustainable Food Systems, Climate, and Global Financial Systems. They provide support to founders through proven programs that enhance access, insight, and relationships necessary for startup growth.
OneBlood
OneBlood, headquartered in Orlando, Florida, is a non-profit organization that specializes in blood donation for hospitals, indicating a focus on healthcare infrastructure and patient care.
PPP
Public-Private Partnership
What's next for Ispecimen?
With a significant strategic investment, Ispecimen is poised for accelerated growth and expansion. This capital infusion is expected to enhance the capabilities of the iSpecimen Marketplace®, potentially broadening its reach and improving its efficiency in connecting researchers with biospecimens. The company's focus on innovation in biospecimen procurement suggests a future trajectory aimed at further solidifying its position as a key facilitator of medical research and discovery.
See full Ispecimen company page
